Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line
about
Debio 025, a cyclophilin binding molecule, is highly efficient in clearing hepatitis C virus (HCV) replicon-containing cells when used alone or in combination with specifically targeted antiviral therapy for HCV (STAT-C) inhibitorsIn Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus GenotypesRelationships between Hepatitis C Virus Replication and CXCL-8 Production In VitroRibavirin Antagonizes the In Vitro Anti-Hepatitis C Virus Activity of 2'-C-Methylcytidine, the Active Component of ValopicitabineProduction of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived CellsThe Level of CD81 Cell Surface Expression Is a Key Determinant for Productive Entry of Hepatitis C Virus into Host CellsIdentification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase ChimerasBlockade of virus infection by human CD4+ T cells via a cytokine relay networkComparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase InhibitorsModeling Subgenomic Hepatitis C Virus RNA Kinetics during Treatment with Alpha InterferonHepatitis C virus replicons: dinosaurs still in business?Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound ScreeningMouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell LineReplication vesicles are load- and choke-points in the hepatitis C virus lifecycle.Theoretical and experimental analysis links isoform-specific ERK signalling to cell fate decisionsDisturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.Completion of hepatitis C virus replication cycle in heterokaryons excludes dominant restrictions in human non-liver and mouse liver cell lines.Bile acids specifically increase hepatitis C virus RNA-replication.New pyrazolobenzothiazine derivatives as hepatitis C virus NS5B polymerase palm site I inhibitors.Stearoyl coenzyme A desaturase 1 is associated with hepatitis C virus replication complex and regulates viral replication.Resolution of chronic hepatitis C following parasitosis.Identification of HNRNPK as regulator of hepatitis C virus particle production.Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.Hepatocellular carcinoma-targeted drug discovery through image-based phenotypic screening in co-cultures of HCC cells with hepatocytesToxicity as a result of immunostimulation by biologics.Cell culture systems for the hepatitis C virusIn vitro models for analysis of the hepatitis C virus life cycle.Synthesis and Anti-HCV Activity of 4-Methoxy-7H-Pyrrolo[2,3-d] Pyrimidine Carbocyclic Nucleosides.Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6).Intracellular effects of the Hepatitis C virus nucleoside polymerase inhibitor RO5855 (Mericitabine Parent) and Ribavirin in combination.Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122.Cell-based hepatitis C virus infection fluorescence resonance energy transfer (FRET) assay for antiviral compound screening.Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A NIGELLA SATIVA SEED FORMULATION.In vitro systems for the study of hepatitis C virus infection.A conformational mimetic approach for the synthesis of carbocyclic nucleosides as anti-HCV leads.Impact of steroids on hepatitis C virus replication in vivo and in vitro.Engineered Livers for Infectious Diseases.
P2860
Q24645702-B1B04021-11AD-4D09-9FE9-E8703ACFF44EQ27468929-29F85030-DC16-4ABE-B901-540666C56FC2Q27477464-178F7D47-ACCD-4FD3-8683-C7AFD2F44B60Q27477522-66FC7E2D-42E3-4200-9DA9-48A52B38783DQ27477544-B57892FB-5E79-4069-A7CF-F082F8DA39AAQ27478044-6BD141FD-CBB2-4F9F-A91A-2E374AC84CF9Q27480357-BD64E4A9-D6E0-4567-8D6E-8F1C51F3F3BEQ27486090-6A220F3F-703D-4B2F-93F9-5F2BE9F28A29Q27486813-835C7613-E02E-4BC5-8825-DF9AF7271837Q27488804-52C59ED2-9ABC-4B89-8A87-E5513A52888CQ27488905-B435CEE0-C26C-4FD1-A81B-EB2B2E029DD4Q27490187-2AD9644E-7E3B-471B-BD0E-447F279585B5Q27490526-6DA7AB95-D1F0-4844-ABBC-8863ED953D16Q31129723-06562528-E997-4678-B4C2-11841ECE39D5Q33668293-BA9D318A-3542-4F57-ABFB-AB5A231E855BQ33837562-EEF591A8-5AC2-4848-8D5A-42CE75970745Q33892350-EC201F70-04AC-43A5-B572-269087393D8CQ34257042-453ADE61-1CED-411F-AAE0-4EFDBD0E42B1Q34372464-F561B849-A5C1-4AC3-9BE9-0DD128EC3E27Q34593867-3BBF6D5E-2A80-4CB7-AAB8-7F5FEF355129Q34662527-09DEFF8E-6BF2-4CE1-ACB0-83ECD37C156DQ34875666-F27A4419-5B1C-419D-A416-B20D24BEB192Q35270150-ACD460AE-821E-462D-BD14-25336254F6D2Q36086311-A70A72F0-82A8-4BFA-8CF4-62B7A15CA017Q36166651-3CE221A7-3153-4F03-8C11-064D85D7AA72Q36788414-45C43EC5-2C01-4BDD-9191-8F6E04B24F94Q36841733-EA7C66A9-E136-436E-B235-93AF7AB2B116Q37965264-12A1E4D0-D445-45ED-B417-956F7F8E704CQ38772817-373E2CAF-BAB8-4F91-B393-EA75CF14F479Q38783715-487E2DB1-1328-4657-9869-78D542176772Q38848491-7407F259-AC6F-437C-9E7F-447A03D127A9Q39437753-2E2D2306-8CD4-4765-8368-87F6DD8912F9Q39660432-D5D684A4-DC55-487C-9354-FDBB35DF21A1Q39968924-65F5D4D4-B7EF-4083-A21E-BABDD1819111Q40099643-ED8A3523-C507-4F4F-AA81-90D3592316AEQ40211530-BCC89954-9BB1-427B-8413-D04586ED8845Q41887493-C576D244-B379-4DE3-9166-3E719E09A991Q42276854-EB860595-D157-4C9F-AB22-70E0E83BBC69Q43041106-0CFEE49A-7FC0-4C22-81A7-6E6CA85A04CDQ47555660-54890BE3-CCBD-42B9-93A7-8FCBC55EF41B
P2860
Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Dissecting the Interferon-Indu ...... y Using a Novel Host Cell Line
@nl
Dissecting the interferon-indu ...... y using a novel host cell line
@ast
Dissecting the interferon-indu ...... y using a novel host cell line
@en
type
label
Dissecting the Interferon-Indu ...... y Using a Novel Host Cell Line
@nl
Dissecting the interferon-indu ...... y using a novel host cell line
@ast
Dissecting the interferon-indu ...... y using a novel host cell line
@en
prefLabel
Dissecting the Interferon-Indu ...... y Using a Novel Host Cell Line
@nl
Dissecting the interferon-indu ...... y using a novel host cell line
@ast
Dissecting the interferon-indu ...... y using a novel host cell line
@en
P2093
P2860
P50
P3181
P1433
P1476
Dissecting the interferon-indu ...... y using a novel host cell line
@en
P2093
Artur Kaul
Marc P Windisch
Martin Trippler
P2860
P304
13778-13793
P3181
P356
10.1128/JVI.79.21.13778-13793.2005
P577
2005-11-01T00:00:00Z